Astellas Pharma US Inc recalls Mycamine (micafungin) for Injection 100 mg/vial Single-Dose Vial Rx only Marketed by: Astellas Pharma US, Inc. Northbro…
- Recall date
- January 22, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0548-2018
- FDA classification
- Class II
- Brand / firm
- Astellas Pharma US Inc
- Sold / distributed
- Nationwide.
Why it was recalled
Labeling: Label Error on Declared Strength
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Mycamine (micafungin) for Injection 100 mg/vial Single-Dose Vial Rx only Marketed by: Astellas Pharma US, Inc. Northbrook, IL 60062, NDC 0469-3211-10
Get recall alerts
Free email alert whenever Astellas Pharma US Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Astellas Pharma US Inc